Aarti Drugs Annual Results

FINANCIALS

Select Period:

Particulars ( Rupees In Crores.)	Mar-2023	Mar-2022	Mar-2021	Mar-2020	Mar-2019
Gross Sales	2716.05	2488.65	2154.78	1806.09	1560.94
Excise Duty	--	--	--	--	--
Net Sales	2716.05	2488.65	2154.78	1806.09	1560.94
Other Operating Income	--	--	--	--	--
Other Income	2.19	11.32	4.74	5.95	6.18
Total Income	2718.24	2499.97	2159.52	1812.04	1567.12
Total Expenditure	2410.45	2159.21	1717.67	1544.27	1353.58
PBIDT	307.79	340.76	441.85	267.77	213.54
Interest	33.29	20.75	22.96	33.73	39.96
PBDT	274.50	320.01	418.89	234.04	173.58
Depreciation	50.32	50.05	49.88	48.75	42.56
Minority Interest Before NP	--	--	--	--	--
Tax	58.86	69.74	93.08	53.34	32.56
Deferred Tax	(1.04)	(4.78)	(4.47)	(9.45)	8.71
Reported Profit After Tax	166.36	205	280.40	141.40	89.75
Minority Interest After NP	0.05	(0.04)	(0.01)	--	--
Net Profit after Minority Interest	166.31	205.04	280.41	141.40	89.75
Extra-ordinary Items	--	--	0.16	3.18	2.58
Adjusted Profit After Extra-ordinary item	166.31	205.04	280.25	138.22	87.17
EPS (Unit Curr.)	17.97	22.12	30.09	60.57	38.48
Book Value (Unit Curr.)	--	--	--	--	--
Dividend (%)	10	10	25	20	10
Equity	92.60	92.60	93.20	23.30	23.58
Public Shareholding (Number)	--	--	--	--	--
Public Shareholding (%)	--	--	--	--	--
Pledged/Encumbered - No. of Shares	--	--	--	--	--
Pledged/Encumbered - % in Total Promoters Holding	--	--	--	--	--
Pledged/Encumbered - % in Total Equity	--	--	--	--	--
Non Encumbered - No. of Shares	--	--	--	--	--
Non Encumbered - % in Total Promoters Holding	--	--	--	--	--
Non Encumbered - % in Total Equity	--	--	--	--	--
PBIDTM(%)	11.33	13.69	20.51	14.83	13.68
PBDTM(%)	10.11	12.86	19.44	12.96	11.12
PATM(%)	6.13	8.24	13.01	7.83	5.75

QuickLinks for Aarti Drugs Ltd.